Unfortunately $45.00 can be correct..Since all good news..This stock has not done any PPS gains...
I was hoping at least go up to 52 week high.. Tsunami, Nuke threat and Gadafi and bad economical data contributed also not to go PPS up at all. Like some one did not take shower..when approval news came...
Advisory pane; +ve vote stock went down..
Approval of benlysta stock has gone down ( so far I have seen after any blockbuster drugs sometimes you see 100% gain) .
HGSI has broke all the records of exception..
MM’s are successful keeping lid on this stock, Goldman is working out deal 9b can get PPS around $45-$50.
GSK CEO has stated they want bolt-on acquisition and HGSI is kind of bolt on for them and GSK has 9B reserved for M&A activities...
Normally, a stock which is stagnant has higher probability of going up.
My gut feeling is it will go up to 45-49$/share
here is my analysis
1) on buyout by GSK - this stock price will be 45-47$/share
2) once marketing happens and earning report comes in, this stock price wil be $55-$60/share
overll, it will be around 60/share
If you're going to post a bogus headline - at least make it somewhat believeable. If GSK makes a move on HGSI you can expect 15% to 20% premium over current share price. $32.50 would be about right at this stage. Chump!
CDLA went up in January about 65% when their drug was approved so what did you expect in Feb when Forest Labs put a bid in. They were already overpriced. So take your comparisons and shove them.
yes, I dont know how to pump up this share.
i am very dissapointed.. it didnt even reach 30$ on approval.
To top it off, it came down to 27 after approval because of option traders,,
i dont think this will go further at all
I think it will revert back to 25-26 again and wait for some news,
next time, if there is a pop up, i will sell this stock..
this is a dead stock which will not go beyond 28
screw this one